Ionic Liquid-coordinated Ytterbium(III) Sulfonate Catalyzed Michael Addition of Indoles
Hz, 2H), 2.79 (t, J=7.2 Hz, 2H), 2.19—2.23 (m,
2H); 19F NMR (376 MHz, D2O) δ: -152.3. Anal. calcd
for C21H45B3F12N6O9S3Yb: C 23.90, H 4.29, B 3.07, F
21.63, N 7.97, Yb 16.4; found C 23.95, H 4.32, B 3.11,
F 21.71, N 7.82, Yb 15.3.
NMR (125 MHz, CDCl3) δ: 156.1, 141.9, 136.4, 125.4,
122.7, 122.3, 119.7, 119.0, 114.8, 111.1, 110.2, 107.1,
46.7, 42.3. Anal. calcd for C14H14N2O: C 74.31, H 6.24,
N 12.38; found C 74.28, H 6.35, N 12.31.
General procedure for Pictet-Spengler reaction of 4
General procedure for Michael addition of indoles to
electron-deficient nitroolefins
To the component solution of BAIL/[bmim]BF4
(m/m=1/5, 10 mL) were added tryptamine 4 (1.30
mmol) and benzaldehyde (1.55 mmol). After being
stirred at 60 ℃ for 8 h, the mixture was cooled and
poured into saturated NaHCO3 solution (50 mL). The
aqueous phase was extracted twice with CH2Cl2. The
combined organic phases were dried over Na2SO4, fil-
tered and concentrated under reduced pressure. Purifica-
tion through flash silica gel column chromatography
afforded compound 5. Data of the new compounds are
shown below.
Indole (1.1 mmol) was added to a suspension of ni-
troolefin (1 mmol) in dried ethanol (8 mL) together with
ionic liquid-coordinated ytterbium(III) sulfonate 1 (5
mmol%). The reaction mixture was heated to 70 ℃ for
2—3 h and then cooled to room temperature. The sol-
vent was removed under reduced pressure, and then
CH2Cl2 was added to dissolve the crude product while
the catalyst 1 was filtered and washed with CH2Cl2 for
next run. The crude product was subjected to flash silica
gel column chromatography to give the pure product.
4-(4-Methoxyphenyl)-1-phenyl-1,2,3,4-tetrahydro-
1
9H-pyrido[3,4-b]indole (5b) m.p. 180—182 ℃; H
General procedure for reduction of 3
NMR (400 MHz, CDCl3, major/minor=92/8) δ: 7.68
(br s, 1H), 7.43—7.35 (m, 5H), 7.23—7.18 (m, 3H),
7.12—7.08 (m, 1H), 6.94—6.87 (m, 4H), 5.32 (d, J=
2.0 Hz, 0.08H), 5.29 (d, J=2.0 Hz, 0.92H), 4.37 (ddd,
J=7.2, 5.2, 2.0 Hz, 1H), 3.83 (s, 3H), 3.54 (dd, J=12.8,
5.2 Hz, 1H), 3.03 (dd, J=12.8, 8.4 Hz, 1H), 1.94 (br s,
1H); 13C NMR (125 MHz, CDCl3) δ: 158.3, 141.6,
136.1, 135.8, 135.2, 129.4, 128.9, 128.8, 128.7, 128.3,
126.8, 121.5, 119.9, 119.2, 113.8, 112.8, 110.9, 60.5,
58.2, 55.3, 52.9, 40.8. Anal. calcd for C24H22N2O: C
81.33, H 6.26, N 7.90; found C 81.42, H 6.37, N 7.79.
4-(4-Chlorophenyl)-1-phenyl-1,2,3,4-tetrahydro-
Pd/C 10% (186 mg) and HCOONH4 (1.15 g) were
sequentially added to a stirred solution of compound 3
(3.56 mmol) in CH3OH (50 mL). The reaction mixture
was stirred at room temperature overnight, then filtered
and the solution was evaporated under reduced pressure.
The white residue was dissolved in EtOAc, washed with
saturated Na2CO3, and the aqueous phase was extracted
twice with EtOAc. The combined organic phases were
dried over Na2SO4, filtered and evaporated to afford
compound 4 as a white solid. The crude product was
used in the next step without further purification. Data
of the new compounds are shown below.
2-(1H-Indol-3-yl)-2-(4-methoxyphenyl)ethanamine
(4b) m.p. 146—147 ℃; 1H NMR (400 MHz, CDCl3) δ:
8.17 (br s, 1H), 7.49 (d, J=8.0 Hz, 1H), 7.34—7.29 (m,
4H), 7.22—7.14 (m, 2H), 7.03 (t, J=7.6 Hz, 2H), 4.25
(t, J=7.2 Hz, 1H), 3.75 (s, 3H), 3.43 (t, J=6.8 Hz, 1H),
3.28 (t, J=6.8 Hz, 1H), 1.49 (br s, NH2); 13C NMR (125
MHz, CDCl3) δ: 158.9, 136.6, 131.2, 128.8, 126.2,
123.7, 121.4, 119.9, 119.0, 114.8, 114.3, 111.4, 55.3,
45.7, 41.8. Anal. calcd for C17H18N2O: C 76.66, H 6.81,
N 10.52; found C 76.72, H 6.93, N 10.61.
2-(4-Chlorophenyl)-2-(1H-indol-3-yl)ethanamine
(4c) m.p. 142—144 ℃; 1H NMR (400 MHz, CDCl3) δ:
8.15 (br s, 1H), 7.47 (d, J=8.0 Hz, 1H), 7.35—7.29 (m,
4H), 7.22—7.15 (m, 2H), 7.03 (t, J=7.6 Hz, 2H), 4.25
(t, J=7.2 Hz, 1H), 3.44 (t, J=6.8 Hz, 1H), 3.29 (t, J=
6.8 Hz, 1H), 1.53 (br s, NH2); 13C NMR (125 MHz,
CDCl3) δ: 137.3, 136.3, 132.1, 128.9, 127.1, 124.0,
122.1, 120.4, 119.8, 115.5, 113.6, 111.3, 47.1, 43.3.
Anal. calcd for C16H15ClN2: C 70.98, H 5.58, N 10.35;
found C 71.06, H 5.51, N 10.27.
1
9H-pyrido[3,4-b]indole (5c) m.p. 168—171 ℃; H
NMR (400 MHz, CDCl3, major/minor=92/8) δ: 7.65
(br s, 1H), 7.39—7.34 (m, 5H), 7.32—7.28 (m, 2H),
7.24—7.21 (m, 2H), 7.18 (d, J=8.0 Hz, 1H), 7.08—
7.04 (m, 1H), 6.89—6.81 (m, 2H), 5.28 (d, J=2.0 Hz,
0.92H), 5.21 (d, J=2.0 Hz, 0.08H), 4.38 (ddd, J=7.2,
5.2, 2.0 Hz, 1H), 3.54 (dd, J=12.8, 5.2 Hz, 1H), 3.03
(dd, J=12.8, 8.0 Hz, 1H), 2.24 (br s, 1H); 13C NMR
(125 MHz, CDCl3) δ: 138.3, 137.1, 136.2, 133.4, 131.5,
129.2, 128.8, 128.6, 128.0, 127.4, 127.1, 122.2, 120.1,
119.2, 112.8, 111.1, 64.4, 59.1, 47.8. Anal. calcd for
C23H19ClN2: C 76.98, H 5.34, N 7.81; found C 76.91, H
5.43, N 7.73.
4-(Furan-2-yl)-1-phenyl-1,2,3,4-tetrahydro-9H-
pyrido[3,4-b]indole (5d) m.p. 103—105 ℃; 1H NMR
(400 MHz, CDCl3, major/minor=77/23) δ: 7.72 (br s,
1H), 7.40—7.31 (m, 6H), 7.28—7.24 (m, 2H), 7.18—
7.11 (m, 1H), 7.09—7.02 (m, 1H), 6.35—6.34 (m,
0.77H), 6.31—6.30 (m, 0.23H), 6.10 (d, J=3.2 Hz,
0.77H), 6.03 (d, J=3.2 Hz, 0.23H), 5.25 (s, 0.77H),
5.19 (s, 0.23H), 4.47 (ddd, J=7.2, 5.2, 2.0 Hz, 0.77H),
4.35 (ddd, J=7.2, 5.2, 2.0 Hz, 0.23H), 3.58 (dd, J=
12.8, 5.2 Hz, 0.23H), 3.49 (dd, J=12.8, 5.2 Hz, 0.77H),
3.39 (dd, J=12.8, 8.4 Hz, 0.23H), 3.28 (dd, J=12.8,
8.4 Hz, 0.77H); 13C NMR (125 MHz, CDCl3) δ: 156.5,
141.7, 141.6, 136.2, 135.3, 129.0, 128.9, 128.3, 126.8,
121.8, 119.5, 119.2, 111.3, 110.4, 110.3, 107.0, 60.7,
2-(Furan-2-yl)-2-(1H-indol-3-yl)ethanamine (4d)
1
m.p. 120—122 ℃; H NMR (400 MHz, CDCl3) δ: 8.16
(br s, 1H), 7.56 (d, J=8.0 Hz, 1H), 7.36 (d, J=8.4 Hz,
2H), 7.21—7.17 (m, 1H), 7.12—7.07 (m, 2H), 6.32—
6.30 (m, 1H), 6.13 (d, J=7.2 Hz, 1H), 4.34 (t, J=6.8
Hz, 1H), 3.40—3.29 (m, 2H), 1.45 (br s, NH2); 13C
Chin. J. Chem. 2010, 28, 443— 448
© 2010 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
447